BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

451 related articles for article (PubMed ID: 12647363)

  • 1. [Pathogenesis of cystic kidney diseases].
    Walz G
    Verh Dtsch Ges Pathol; 2002; 86():138-44. PubMed ID: 12647363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autosomal dominant polycystic kidney disease (ADPKD, MIM 173900, PKD1 and PKD2 genes, protein products known as polycystin-1 and polycystin-2).
    Boucher C; Sandford R
    Eur J Hum Genet; 2004 May; 12(5):347-54. PubMed ID: 14872199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
    Wu G; Somlo S
    Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genes homologous to the autosomal dominant polycystic kidney disease genes (PKD1 and PKD2).
    Veldhuisen B; Spruit L; Dauwerse HG; Breuning MH; Peters DJ
    Eur J Hum Genet; 1999 Dec; 7(8):860-72. PubMed ID: 10602361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic mutation as mechanism for cyst formation in autosomal dominant polycystic kidney disease.
    Qian F; Watnick TJ
    Mol Genet Metab; 1999 Oct; 68(2):237-42. PubMed ID: 10527675
    [No Abstract]   [Full Text] [Related]  

  • 6. Polycystins: what polycystic kidney disease tells us about sperm.
    Kierszenbaum AL
    Mol Reprod Dev; 2004 Apr; 67(4):385-8. PubMed ID: 14991728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Haploinsufficiency of Pkd2 is associated with increased tubular cell proliferation and interstitial fibrosis in two murine Pkd2 models.
    Chang MY; Parker E; Ibrahim S; Shortland JR; Nahas ME; Haylor JL; Ong AC
    Nephrol Dial Transplant; 2006 Aug; 21(8):2078-84. PubMed ID: 16720597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perinatal lethality with kidney and pancreas defects in mice with a targetted Pkd1 mutation.
    Lu W; Peissel B; Babakhanlou H; Pavlova A; Geng L; Fan X; Larson C; Brent G; Zhou J
    Nat Genet; 1997 Oct; 17(2):179-81. PubMed ID: 9326937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents.
    Hanaoka K; Qian F; Boletta A; Bhunia AK; Piontek K; Tsiokas L; Sukhatme VP; Guggino WB; Germino GG
    Nature; 2000 Dec 21-28; 408(6815):990-4. PubMed ID: 11140688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene.
    Boulter C; Mulroy S; Webb S; Fleming S; Brindle K; Sandford R
    Proc Natl Acad Sci U S A; 2001 Oct; 98(21):12174-9. PubMed ID: 11593033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The PKD1 gene product, "polycystin-1," is a tyrosine-phosphorylated protein that colocalizes with alpha2beta1-integrin in focal clusters in adherent renal epithelia.
    Wilson PD; Geng L; Li X; Burrow CR
    Lab Invest; 1999 Oct; 79(10):1311-23. PubMed ID: 10532593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects in cell polarity underlie TSC and ADPKD-associated cystogenesis.
    Bonnet CS; Aldred M; von Ruhland C; Harris R; Sandford R; Cheadle JP
    Hum Mol Genet; 2009 Jun; 18(12):2166-76. PubMed ID: 19321600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular polycystins: insights from autosomal dominant polycystic kidney disease and transgenic animal models.
    Bichet D; Peters D; Patel AJ; Delmas P; Honoré E
    Trends Cardiovasc Med; 2006 Nov; 16(8):292-8. PubMed ID: 17055386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current advances in molecular genetics of autosomal-dominant polycystic kidney disease.
    Wu G
    Curr Opin Nephrol Hypertens; 2001 Jan; 10(1):23-31. PubMed ID: 11195048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypes of autosomal dominant polycystic kidney disease in Japanese.
    Mizoguchi M; Tamura T; Yamaki A; Higashihara E; Shimizu Y
    J Hum Genet; 2002; 47(1):51-4. PubMed ID: 11829141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutations of PKD1 in ADPKD2 cysts suggest a pathogenic effect of trans-heterozygous mutations.
    Watnick T; He N; Wang K; Liang Y; Parfrey P; Hefferton D; St George-Hyslop P; Germino G; Pei Y
    Nat Genet; 2000 Jun; 25(2):143-4. PubMed ID: 10835625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PKD1 and PKD2 mutations in Slovenian families with autosomal dominant polycystic kidney disease.
    Vouk K; Strmecki L; Stekrova J; Reiterova J; Bidovec M; Hudler P; Kenig A; Jereb S; Zupanic-Pajnic I; Balazic J; Haarpaintner G; Leskovar B; Adamlje A; Skoflic A; Dovc R; Hojs R; Komel R
    BMC Med Genet; 2006 Jan; 7():6. PubMed ID: 16430766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of PKD1 causes polycystic kidney disease.
    Thivierge C; Kurbegovic A; Couillard M; Guillaume R; Coté O; Trudel M
    Mol Cell Biol; 2006 Feb; 26(4):1538-48. PubMed ID: 16449663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of heterozygosity in renal and hepatic epithelial cystic cells from ADPKD1 patients.
    Badenas C; Torra R; Pérez-Oller L; Mallolas J; Talbot-Wright R; Torregrosa V; Darnell A
    Eur J Hum Genet; 2000 Jul; 8(7):487-92. PubMed ID: 10909847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autosomal dominant polycystic kidney disease: clues to pathogenesis.
    Harris PC
    Hum Mol Genet; 1999; 8(10):1861-6. PubMed ID: 10469838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.